Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Signed Informed Consent~* Men and women ≥ 19 years of age~* Subject who has one of 3 conditions classified by Cardiovascular Risk Factors, 10-Year Risk, Blood Pressure, LDL-C, TG, Coronary Artery Disease and Equivalent~Exclusion Criteria:~* Females who are pregnant, breastfeeding, or of childbearing potential, unwilling to practice adequate contraception throughout the study.~* Other exclusions applied

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- YH16410 (Type: EXPERIMENTAL): PO, Once Daily, 8 weeks
- Rosuvastatin (Type: ACTIVE_COMPARATOR): PO, Once Daily, 8 weeks
- Telmisartan (Type: ACTIVE_COMPARATOR): PO, Once Daily, 8 weeks
- Placebo (Type: PLACEBO_COMPARATOR): PO, Once Daily, 8 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).